Schroder Investment Management Group
KRTX

Schroder Investment Management Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Schroder Investment Management Group’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-26,843
Closed -$8.5M – 1264
2023
Q4 		$8.5M Buy
26,843
+4,067
+18% +$791K 0.01% 668
2023
Q3 		$3.85M Sell
22,776
-1,919
-8% -$361K 0.01% 802
2023
Q2 		$5.36M Buy
+24,695
New +$5.29M 0.01% 774

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Schroder Investment Management Group's KRTX Position: Q1 2024 in Review

Schroder Investment Management Group sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 26,843 shares — an estimated $8.5M sold.

Schroder Investment Management Group first reported a position in KRTX in Q2 2023 and held it in 3 quarters. The position peaked at $8.5M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Schroder Investment Management Group reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Schroder Investment Management Group sold 26,843 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $8.5M.
  • Schroder Investment Management Group first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • Schroder Investment Management Group's Karuna Therapeutics, Inc. Common Stock position peaked at $8.5M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Schroder Investment Management Group's 13F filing for Q1 2024, filed 14 May 2024.